Obesity

SEP 11, 2026 · INTERVENTIONAL STUDY

The COCCOS Study: a Transition Program for Young Persons With Chronic Conditions

ClinicalTrials.gov

This is a registry record describing an active, non-recruiting feasibility study with no results posted; it documents planned enrollment and design only.

SEP 11, 2026 · PHASE 1 TRIAL

A Research Study Looking at the Effect of Timing of Meal After Dosing and Water Volume at Dosing on How the Medicine Zenagamtide is Taken up by the Body of Participants With Overweight or Obesity

ClinicalTrials.gov

Phase 1 registry record with no results posted; describes a planned bioavailability study designed to measure food and water effects on zenagamtide absorption in an estimated 320 participants with overweight or obesity.

SEP 11, 2026 · PHASE 2 TRIAL

A Study of Tirzepatide (LY3298176) in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes

ClinicalTrials.gov

Phase 2 registry record with completed enrollment but no results posted; insufficient to assess efficacy or safety, only study design and conduct are known.

SEP 11, 2026 · INTERVENTIONAL STUDY

Cities for Better Health Childhood Obesity Prevention Initiative

ClinicalTrials.gov

This is a study registration for an ongoing community-based intervention trial with no results reported; enrollment is active and follow-up data collection is not yet complete.

SEP 11, 2026 · PHASE EARLY PHASE 1 TRIAL

Tirzepatide in Obesity-Driven Endometrial Cancer

ClinicalTrials.gov

This is an early-phase, uncontrolled window-of-opportunity study with a planned sample of 20 patients examining a mechanistic hypothesis in a pre-operative setting; no results are yet reported.

SEP 11, 2026 · PHASE 1/2 TRIAL

First-in-human Study of the Safety, Tolerability, Pharmacokinetics, and Food Effect of ACCG-2671

ClinicalTrials.gov

This is a first-in-human Phase 1/2 trial registration with no results posted; it describes planned safety, tolerability, and pharmacokinetic endpoints in an ongoing recruitment study.

SEP 11, 2026 · PHASE 3 TRIAL

AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea

ClinicalTrials.gov

This is a Phase 3 trial registration with no results posted; the study is actively recruiting and has not yet reported efficacy or safety outcomes.

SEP 10, 2026 · OBSERVATIONAL STUDY

Safety and Effectiveness of Orbera365™ Intragastric Balloon System

ClinicalTrials.gov

This is a prospective observational registry of an already-marketed device with no posted results; it is designed to monitor safety and completion rates in routine practice but carries no efficacy data and is not yet reported.